We are executive search and leadership development specialists working to build a better future. As advisors and consultants to companies at the cutting edge of Health, Science, and Technology, we are united by our mission to build teams that change the world. Operating uniquely as one global team, we have honed our expertise, platform, and data for over two decades, working across three continents, and in 40 countries. Applying what we learn through our work with boards, leadership teams, and investors in the world’s most innovative companies, we bring together and develop the right people at the right time to propel them to achieve their worthwhile goals.
The Coulter Partners team is made up of 110 experts, working in 40 countries, holding 250,000 conversations with industry leaders each year. Together we channel data and learning to the benefit of our clients. We are a diverse group of experts with backgrounds ranging from science and technology, to the arts, finance, and more. Our reward system is designed to drive one-team behaviors and we work together seamlessly to combine industry experience and global insight with our passion for progress. Our team understands and is up to date with the challenges you face and the opportunities your business can maximize. This means we can find and develop exceptional individuals to drive you forward.
Our network is carefully curated and gives us access to leaders who can guide science, technology and innovation-driven companies through all stages of growth and evolution. Our executive search is an end-to-end process, underpinned by rigorous data and analytics from our dedicated Business Intelligence function and CP:Net™, our proprietary AI-driven candidate and company database. Our Board Advisory brings over two decades’ experience in building, advising and evolving boards for private and public companies. We understand what value a board can bring and how to evaluate its suitability for the stage of the business and the 3–5-year plan. We also provide leadership advisory at every step of the way. We have a network of mentors and advisors that bring the next level of insight to your organization, to build teams that change the world.
Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Gerben van ‘t Klooster as chief development officer for TargED Biopharmaceuticals in London. “We are thrilled to welcome Gerben to our team at TargED Biopharmaceuticals,” said Kristof Vercruysse, CEO of TargED Biopharmaceuticals. “He brings a wealth of experience and expertise that will be invaluable to our
Healthcare and life science organizations are facing an increasingly complex landscape, with rapid technological advancements, changing regulatory environments, and heightened public scrutiny. As a result, these companies have been turning to executive search firms more than ever to land world-class leadership. The most pressing challenge has been finding high-impact, innovative leaders who can navigate this
Life sciences recruiting specialist Coulter Partners has assisted in the recruitment of Francesco Marincola as chief scientific officer of Sonata Therapeutics Inc., a biotechnology company in Boston. “Throughout his successful career across academia and industry over the last few decades, Franco has stood at the forefront of discovery and drug development,” said Volker Herrmann, president and CEO of
Life sciences recruiting specialist Coulter Partners has placed three board directors—Cristina Ortega Duran, Andy Richards, and Simon Sturge—for Our Future Health Trading Ltd., the trading subsidy of Our Future Health, a U.K.-based collaborative health research program. “It has been our privilege to work with Coulter Partners over the last six months with our recruitment of three non-executive
Coulter Partners is proud of the successful placement of Dr. Stuart Hughes as Chief Executive Officer at Nuage Therapeutics S.L. (“Nuage”). Nuage is a biotech company focused on creating transformational precision therapies by targeting established oncogenic transcription factors. The Company has developed a set of tools that enables the reconstitution of intrinsically-disordered proteins (IDPs) in
Coulter Partners successfully completed a search assignment for Tozaro and is pleased to announce the placement of Dr. Jason Slingsby, MBA as Chief Executive Officer. Tozaro is a pioneering technology provider specializing in cell and gene therapy manufacturing. The company focuses on advancing its Smart Polymer technology to revolutionize downstream processing in this field. With
Coulter Partners recently partnered with MTIP and Coramaze Technologies (Coramaze) and is pleased to announce the placement of Rob ten Hoedt as Chair of Coramaze’s Board of Directors. Coramaze Technologies is a pre-commercial medical technology company, focused on developing a novel tricuspid valve repair system, called Tripair™, a minimally invasive solution for treating tricuspid regurgitation
Coulter Partners successfully completed a search assignment for Clinical Partners and is pleased to announce the placement of Luis De Miguel Puig as Chief Data and Technology Officer (CDTO). Clinical Partners is a UK leading provider of mental health services which works both privately and with the NHS to help people and families experiencing mental
Coulter Partners successfully completed a search assignment for iOnctura and is pleased to announce the placement of Dr. Mark Velleca as Chair of the Board of Directors. iOnctura is a clinical-stage precision oncology company combating neglected and hard-to-treat cancers with a pipeline of first-in-class small molecules. Dr. Mark Velleca is currently the CEO and Board Chair of Black Diamond Therapeutics (BDTX) and
News
Top hires for Q3-2025
Top hires for Q2-2025
Coulter Partners: Fostering Digital Health connections on the Seine
Coulter Partners at BIA Women in Biotech: Driving diversity in Life Sciences leadership
Coulter Partners joins key discussion on HealthTech Boards at NHS Innovation Accelerator day
Coulter Partners at the BIA Life Science Leadership Summit: Fostering Board Excellence and UK Biotech Growth!
Coulter Partners attends LabCentral’s Luminescence: Rise & Fund event in Boston, MA
Leadership in MedTech: Key insights from our Paris roundtable
Coulter Partners co-hosts premier UK HealthTech Super Connector event
Coulter Partners attends Bio€quity Europe in Bruges, Belgium
Coulter Partners attends Danish Biotech Spring Gala
Top hires for VC & PE portfolio companies Q1-2025
Evolution Italy: Life Science leaders gather for insightful discussions
Coulter Partners at BioCapital Europe 2025: Innovation and optimism reign
BioInnovation Institute Breakfast Seminar Health Tech Ecosystem – Copenhagen
BIA Gala Dinner 2025
Top hires for VC & PE portfolio companies Q4-2024
Top global hires for large-cap, mid-cap and public companies H2-2024